Yield10 Bioscience Stock Buy Hold or Sell Recommendation
| YTEN Stock | USD 0 0 100.00% |
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding Yield10 Bioscience is 'Strong Sell'. The recommendation algorithm takes into account all of Yield10 Bioscience's available fundamental, technical, and predictive indicators you will find on this site.
Check out Yield10 Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide. In addition, we conduct extensive research on individual companies such as Yield10 and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Yield10 Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Yield10 |
Execute Yield10 Bioscience Buy or Sell Advice
The Yield10 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Yield10 Bioscience. Macroaxis does not own or have any residual interests in Yield10 Bioscience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Yield10 Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Yield10 Bioscience Trading Alerts and Improvement Suggestions
| Yield10 Bioscience generated a negative expected return over the last 90 days | |
| Yield10 Bioscience has high historical volatility and very poor performance | |
| Yield10 Bioscience has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 60 K. Net Loss for the year was (14.46 M) with loss before overhead, payroll, taxes, and interest of (6.46 M). | |
| Yield10 Bioscience currently holds about 10.16 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Yield10 Bioscience has a frail financial position based on the latest SEC disclosures | |
| Roughly 18.0% of the company outstanding shares are owned by insiders |
Yield10 Bioscience Returns Distribution Density
The distribution of Yield10 Bioscience's historical returns is an attempt to chart the uncertainty of Yield10 Bioscience's future price movements. The chart of the probability distribution of Yield10 Bioscience daily returns describes the distribution of returns around its average expected value. We use Yield10 Bioscience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Yield10 Bioscience returns is essential to provide solid investment advice for Yield10 Bioscience.
| Mean Return | -0.58 | Value At Risk | -31.43 | Potential Upside | 66.67 | Standard Deviation | 28.87 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Yield10 Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Yield10 Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Yield10 Bioscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Yield10 Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Yield10 stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | -5.35 | |
σ | Overall volatility | 28.88 | |
Ir | Information ratio | -0.02 |
Yield10 Bioscience Volatility Alert
Yield10 Bioscience is displaying above-average volatility over the selected time horizon. Yield10 Bioscience is a penny stock. Even though Yield10 Bioscience may be a good instrument to invest, many penny stocks are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Yield10 Bioscience or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Yield10 instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Yield10 Bioscience Fundamentals Vs Peers
Comparing Yield10 Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Yield10 Bioscience's direct or indirect competition across all of the common fundamentals between Yield10 Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Yield10 Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Yield10 Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Yield10 Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Yield10 Bioscience to competition |
| Fundamentals | Yield10 Bioscience | Peer Average |
| Return On Equity | -15.08 | -0.31 |
| Return On Asset | -1.78 | -0.14 |
| Operating Margin | (7.12) % | (5.51) % |
| Current Valuation | 2.06 M | 16.62 B |
| Shares Outstanding | 692.68 K | 571.82 M |
| Shares Owned By Insiders | 17.54 % | 10.09 % |
| Shares Owned By Institutions | 0.03 % | 39.21 % |
| Number Of Shares Shorted | 60.7 K | 4.71 M |
| Price To Earning | (3.19) X | 28.72 X |
| Price To Book | 11.23 X | 9.51 X |
| Price To Sales | 0.46 X | 11.42 X |
| Revenue | 60 K | 9.43 B |
| Gross Profit | (6.46 M) | 27.38 B |
| EBITDA | (14.13 M) | 3.9 B |
| Net Income | (14.46 M) | 570.98 M |
| Cash And Equivalents | 10.16 M | 2.7 B |
| Cash Per Share | 2.07 X | 5.01 X |
| Total Debt | 3.21 M | 5.32 B |
| Debt To Equity | 0.28 % | 48.70 % |
| Current Ratio | 6.58 X | 2.16 X |
| Book Value Per Share | (9.71) X | 1.93 K |
| Cash Flow From Operations | (10.07 M) | 971.22 M |
| Short Ratio | 0.03 X | 4.00 X |
| Earnings Per Share | (20.14) X | 3.12 X |
| Target Price | 2.5 | |
| Number Of Employees | 29 | 18.84 K |
| Beta | 1.43 | -0.15 |
| Market Capitalization | 345.46 K | 19.03 B |
| Total Asset | 3.91 M | 29.47 B |
| Retained Earnings | (414.15 M) | 9.33 B |
| Working Capital | (3.46 M) | 1.48 B |
| Current Asset | 15.34 M | 9.34 B |
| Current Liabilities | 3.91 M | 7.9 B |
Note: Disposition of 1400 shares by Schuler Jack W of Yield10 Bioscience at 2.53 subject to Rule 16b-3 [view details]
Yield10 Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Yield10 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 2.0 | |||
| Day Median Price | 0.002 | |||
| Day Typical Price | 0.002 | |||
| Price Action Indicator | 5.0E-4 | |||
| Period Momentum Indicator | 0.001 |
About Yield10 Bioscience Buy or Sell Advice
When is the right time to buy or sell Yield10 Bioscience? Buying financial instruments such as Yield10 Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Yield10 Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gambling Thematic Idea Now
Gambling
Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Yield10 Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.